Dr Reddys Laboratories (RDY) Long-Term Investments (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Long-Term Investments of $848.23 million for the quarter ended Jun 30, 2026, up 25.8% from $674.02 million a year earlier but down 6.7% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Long-Term Investments (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories' Long-Term Investments came in at $772 million, up 52.6% from the prior year.
- Annual Long-Term Investments shows a five-year compound annual growth rate of 23.4% (years ended Mar 2021 to Mar 2026).
- In prior years, Dr Reddys Laboratories' Long-Term Investments was $506 million in the year ended Mar 31, 2025 (-43.7%), $898.31 million in the year ended Mar 31, 2024 (+36.1%), $660 million in the year ended Mar 31, 2023 (+69.7%) and $389 million in the year ended Mar 31, 2022 (+44.1%).
- Quarterly Long-Term Investments has run from a low of -$1.07 billion in the quarter ended Dec 31, 2022 to a high of $909.49 million in the quarter ended Mar 31, 2026 over five years.
- On a year-over-year basis, Long-Term Investments has increased in each of the last four quarters, with growth averaging 14.1% over the last six quarters.
- The strongest year-over-year quarter for Long-Term Investments in the past five years was the quarter ended Mar 31, 2026, with growth of 82.1%; the weakest was the quarter ended Mar 31, 2025, with a decline of 44.2%.
- According to Business Quant data, Long-Term Investments for the three prior quarters was $909.49 million (quarter ended Mar 31, 2026), $769.6 million (quarter ended Dec 31, 2025) and $686.81 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | - |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | - |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Dr Reddys Laboratories | 10.90 Bn | 10.27 Bn | 396.53 Mn | 847.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 847.17 Mn |
| Mar 31, 2026 | 60.12 Mn |
| Dec 31, 2025 | 763.45 Mn |
| Sep 30, 2025 | 675.34 Mn |
| Jun 30, 2025 | 750.86 Mn |
| Mar 31, 2025 | 56.24 Mn |
| Dec 31, 2024 | 596.43 Mn |
| Sep 30, 2024 | 618.09 Mn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | 50.32 Mn |
| Dec 31, 2023 | 839.96 Mn |
| Sep 30, 2023 | 676.08 Mn |
| Jun 30, 2023 | 657.13 Mn |
| Mar 31, 2023 | 57.27 Mn |
| Dec 31, 2022 | 530.03 Mn |
| Sep 30, 2022 | 248.03 Mn |
| Jun 30, 2022 | 369.73 Mn |
| Mar 31, 2022 | 56.94 Mn |
| Dec 31, 2021 | 209.32 Mn |
| Sep 30, 2021 | 244.99 Mn |
API Access
Dr Reddys Laboratories Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();